Cargando…
Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programs
The ability to support a comprehensive vaccine research and development (R&D) portfolio from a health security perspective has taken on enhanced significance over the past 3 years whereby countries that had existing vaccine R&D infrastructure (G7, Russia and China) have been at the forefront...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017735/ https://www.ncbi.nlm.nih.gov/pubmed/36935694 http://dx.doi.org/10.3389/fpubh.2023.1143790 |
_version_ | 1784907655176781824 |
---|---|
author | Hare, Jonathan Riggall, Giovanna Bongers, Alexander Ramesh, Kirthi Kokareva, Larissa Chin, Brian |
author_facet | Hare, Jonathan Riggall, Giovanna Bongers, Alexander Ramesh, Kirthi Kokareva, Larissa Chin, Brian |
author_sort | Hare, Jonathan |
collection | PubMed |
description | The ability to support a comprehensive vaccine research and development (R&D) portfolio from a health security perspective has taken on enhanced significance over the past 3 years whereby countries that had existing vaccine R&D infrastructure (G7, Russia and China) have been at the forefront of global efforts to combat COVID-19. Few countries outside of these key players have the infrastructure necessary to develop national vaccine programs, though this is beginning to change with investment across many low- and middle-income countries. These same opportunities exist for countries in Central and West Asia, and in this perspective, we highlight the existing infrastructure and expertise across seven countries (Armenia, Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, Tajikistan, and Uzbekistan) and propose opportunities for enhanced collaboration along with a bold proposal for establishing a new-build, regional vaccine translational research institute to facilitate the development of a robust, regional vaccine R&D environment to combat existing and future health challenges. |
format | Online Article Text |
id | pubmed-10017735 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100177352023-03-17 Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programs Hare, Jonathan Riggall, Giovanna Bongers, Alexander Ramesh, Kirthi Kokareva, Larissa Chin, Brian Front Public Health Public Health The ability to support a comprehensive vaccine research and development (R&D) portfolio from a health security perspective has taken on enhanced significance over the past 3 years whereby countries that had existing vaccine R&D infrastructure (G7, Russia and China) have been at the forefront of global efforts to combat COVID-19. Few countries outside of these key players have the infrastructure necessary to develop national vaccine programs, though this is beginning to change with investment across many low- and middle-income countries. These same opportunities exist for countries in Central and West Asia, and in this perspective, we highlight the existing infrastructure and expertise across seven countries (Armenia, Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, Tajikistan, and Uzbekistan) and propose opportunities for enhanced collaboration along with a bold proposal for establishing a new-build, regional vaccine translational research institute to facilitate the development of a robust, regional vaccine R&D environment to combat existing and future health challenges. Frontiers Media S.A. 2023-03-02 /pmc/articles/PMC10017735/ /pubmed/36935694 http://dx.doi.org/10.3389/fpubh.2023.1143790 Text en Copyright © 2023 Hare, Riggall, Bongers, Ramesh, Kokareva and Chin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Hare, Jonathan Riggall, Giovanna Bongers, Alexander Ramesh, Kirthi Kokareva, Larissa Chin, Brian Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programs |
title | Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programs |
title_full | Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programs |
title_fullStr | Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programs |
title_full_unstemmed | Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programs |
title_short | Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programs |
title_sort | vaccine research and development capacity in central and west asia: a path toward sustainable vaccine r&d programs |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017735/ https://www.ncbi.nlm.nih.gov/pubmed/36935694 http://dx.doi.org/10.3389/fpubh.2023.1143790 |
work_keys_str_mv | AT harejonathan vaccineresearchanddevelopmentcapacityincentralandwestasiaapathtowardsustainablevaccinerdprograms AT riggallgiovanna vaccineresearchanddevelopmentcapacityincentralandwestasiaapathtowardsustainablevaccinerdprograms AT bongersalexander vaccineresearchanddevelopmentcapacityincentralandwestasiaapathtowardsustainablevaccinerdprograms AT rameshkirthi vaccineresearchanddevelopmentcapacityincentralandwestasiaapathtowardsustainablevaccinerdprograms AT kokarevalarissa vaccineresearchanddevelopmentcapacityincentralandwestasiaapathtowardsustainablevaccinerdprograms AT chinbrian vaccineresearchanddevelopmentcapacityincentralandwestasiaapathtowardsustainablevaccinerdprograms |